Danaher Corp. (DHR) Company Profile & Statistics

Danaher Corp.
DHR
(NYSE)
Closed
235.05
+1.95 (+0.84%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
After Market:234.34-0.71 (-0.30%)
Open
233.93
High
235.18
Low
230.53

About Danaher Corp.

CEO

Rainer M. Blair

Headquarters

2200 pennsylvania ave. n.w, suite 800w

washington, dc 20037, united states

Auditor

Ernst & Young LLP

Employees

63,000

Share Holders

2,191

Website

www.danaher.com

Industry

medical specialties

Sector

health technology

Company Overview

Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.

Danaher Corp. Statistics

Valuation Measures

Market Capitalization ²	169.77B
Enterprise Value	184.67B
Enterprise Value/EBITDA (ttm)	25.93
Price to Earnings Ratio (ttm)	31.03
Price to Book (mrq)	3.25
Price to Sales (ttm)	7.02
Price to Cash (ytd)	21.79

Profitability

Gross Margin (ttm)	59.38%
Operating Margin (ttm)	23.28%
Profit Margin (ttm)	16.38%
Return on Equity (ttm)	10.62%
Return on Invested Capital (ttm)	5.73%
Return on Assets (ttm)	6.76%

Income Statement

Revenue (ttm)	23.74B
Revenue Per Share (ttm)	32.87
Gross Profit (ttm)	14.10B
EBITDA (ttm)³	7.12B
Net Income Avi to Common (ttm)	3.89B
Diluted EPS (ttm)	5.24

Share Statistics

Beta (5Y Monthly)	0.85
52-Week Change	11.85%
S&P500 52-Week Change	30.55%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	722.28M
Dividend Yield	0.47%
Float ⁴	642.10M
% Held by Insiders	11.10%
% Held by Institutions	79.05%

Balance Sheet

Total Cash (mrq)	2.63B
Total Cash Per Share (mrq)	3.64
Total Debt (mrq)	17.52B
Total Debt/Equity (mrq)	34.16%
Current Ratio (mrq)	1.37%
Quick Ratio (mrq)	1.01%
Book Value Per Share (mrq)	71.04

Cash Flow

Operating Cash Flow Per Share (ytd)	6.40
Free Cash Flow (ytd)	3.81B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Danaher Corp.

Trade With A Regulated Broker